2021
DOI: 10.1016/j.oraloncology.2021.105483
|View full text |Cite
|
Sign up to set email alerts
|

Impact of sarcopenia in locally advanced head and neck cancer treated with chemoradiation: An Indian tertiary care hospital experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(13 citation statements)
references
References 28 publications
0
8
0
Order By: Relevance
“…Comparable associations for disease-specific survival (DSS) were found in 5 studies for patients treated by surgery (HR 2.96, 95% CI: 0.73–11.95) and radiotherapy (HR 2.67, 95% CI: 1.51–4.73) [51]. These results were confirmed in more recent studies [28,52,53].…”
Section: Survivalmentioning
confidence: 70%
See 1 more Smart Citation
“…Comparable associations for disease-specific survival (DSS) were found in 5 studies for patients treated by surgery (HR 2.96, 95% CI: 0.73–11.95) and radiotherapy (HR 2.67, 95% CI: 1.51–4.73) [51]. These results were confirmed in more recent studies [28,52,53].…”
Section: Survivalmentioning
confidence: 70%
“…Although patients with low SMM did not have a decreased OS, patients who experienced DLT did have a significantly decreased OS (HR 2.11) [27]. In 300 HNC patients treated with definitive chemoradiotherapy, patients with low SMI were more likely to experience moderate to severe toxicities and more treatment gaps [28]. In 82 naso-pharyngeal cancer patients treated by concurrent platin-based chemoradiotherapy, low SMM (91%) was associated with DLT defined as the need to reduce the drug dose, to delay, or definitively to discontinue the protocol (OR 4.00, 95% CI: 1.20-13.36) [29].…”
Section: Toxicity Of Anti-cancer Drugsmentioning
confidence: 96%
“…Cachexia is associated with inadequate food intake, metabolic derangement, inactivity, loss of muscle mass, and weight loss in patients with advanced malignant tumors ( 17 ). More toxicities, treatment gaps, and postoperative complications as well as poorer disease-free survival are generally contributed by cachexia ( 19 ). Fukuta et al.…”
Section: Discussionmentioning
confidence: 99%
“…Cachexia is related to weight loss, inadequate food intake, inactivity, loss of muscle mass, and metabolic derangement in patients with advanced cancer ( 16 ). It could result in more toxicities, poorer disease-free survival, and more treatment gaps ( 20 ). More importantly, postoperative complications are associated with cachexia.…”
Section: Discussionmentioning
confidence: 99%